Pyrimido compounds having antiproliferative activity
US7084270B2 · kind B2 · utility
18Cited by
6References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2003 |
| Grant date | Aug 1, 2006 |
| Priority date | — |
| Expiry date | Sep 18, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel pyrimido compounds that are selective inhibitors of both KDR an FGFR kinases and are selective against LCK. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and methods of treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.